IC Sub Cohort Types,"Exposed IC Population (6,089)",% of Exposed (*),"Unexposed IC Population (113,831)",% of Unexposed (*)
"Active treatment with high-dose corticosteroids, immunosuppressive or immunomodulatory therapy",1534,25.20%,16938,14.88%
Advanced or untreated human immunodeficiency virus (HIV) infection,32,0.53%,4246,3.73%
ESRD or dialysis treatment,694,11.39%,36096,31.71%
Moderate or severe primary immunodeficiency,3371,55.37%,30165,26.50%
Receipt of chimeric antigen receptor T-cell (CAR-T) or hematopoietic stem cell transplant (HSCT),776,12.74%,4633,4.07%
Receipt of solid organ or islet transplant,1774,29.14%,40080,35.21%
Solid tumors or hematological malignancies not on treatment,3562,58.50%,20376,17.90%
Solid tumors or hematological malignancies on treatment,2904,47.69%,2857,2.51%
